tm
Seeing Is Believing
tm
Seeing Is Believing
CLDX is currently covered by 9 analysts with an average price target of $49.24. This is a potential upside of $36.05 (19.92%) from yesterday's end of day stock price of $41.06.
Celldex Therapeutics's activity chart (see below) currently has 89 price targets and 97 ratings on display. The stock rating distribution of CLDX is 93.33% BUY and 6.67% HOLD.
Analysts average stock forecasts to be materialized ratio is 20.81% with an average time for these price targets to be met of 71.1 days.
Highest price target for CLDX is $72, Lowest price target is $24, average price target is $49.24.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO on 29-Jul-2026. First documented stock forecast 19-Jun-2013.
Currently out of the existing stock ratings of CLDX, 14 are a BUY (93.33%), 1 are a HOLD (6.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Aug-2025
$72
$33.94 (89.17%)
$48
Buy Since 21-Feb-2020
$61
$22.94 (60.27%)
$67
Buy Since 20-Mar-2025
$40
$1.94 (5.10%)
$43
Buy Since 28-Apr-2025
$60
$21.94 (57.65%)
$62
Buy Since 23-Feb-2021
$42
$3.94 (10.35%)
$42
What is CLDX (Celldex Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CLDX (Celldex Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CLDX (Celldex Therapeutics)?
Which analyst is the currently most bullish on CLDX (Celldex Therapeutics)?
Which analyst is the currently most reserved on CLDX (Celldex Therapeutics)?
